GlaxoSmithKline reported 17.57B in Current Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Amgen AMGN:US $ 19099M 2200M
AstraZeneca AZN:LN 27.27B 8.54B
Bayer BAYN:GR 32.45B 3.35B
Biogen BIIB:US $ 7183.7M 464.2M
Bristol Myers Squibb BMY:US $ 29161M 2050M
Eli Lilly And LLY:US $ 17295.5M 691M
Fresenius FRE:GR € 16901M 208M
Fresenius Medical Care FME:GR € 7815M 26M
Galapagos GLPG:NA 5.13B 181.43M
Genmab GEN:DC 20.3B 367M
Gilead Sciences GILD:US $ 14498M 1220M
GlaxoSmithKline GSK:LN 17.57B 958M
Glaxosmithkline GSK:US $ 17566M 958M
GRIFOLS GRF:SM € 3239.5M 153.93M
H. Lundbeck A/S LUN:DC 8.15B 38M
Hikma Pharmaceutical HIK:LN 1.96B 33M
Lonza Group LONN:SW 5.03B 229M
Merck MRK:GR € 10182M 435M
Novartis NOVN:VX 23.81B 1.61B
Orion ORNBV:FH 616M 163.1M
Recordati REC:IM 907.38M 46.06M
Regeneron Pharmaceuticals REGN:US $ 13337.6M 3282.5M